Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 17, 2023

BUY
$323.56 - $373.36 $29,443 - $33,975
91 Added 4.39%
2,166 $807,000
Q4 2022

Mar 06, 2023

BUY
$248.67 - $334.17 $3,978 - $5,346
16 Added 0.78%
2,075 $685,000
Q3 2022

Nov 02, 2022

SELL
$263.81 - $337.27 $48,804 - $62,394
-185 Reduced 8.24%
2,059 $542,000
Q2 2022

Aug 12, 2022

BUY
$301.4 - $428.42 $67,212 - $95,537
223 Added 11.03%
2,244 $701,000
Q1 2022

May 13, 2022

BUY
$379.46 - $424.54 $6,450 - $7,217
17 Added 0.85%
2,021 $843,000
Q4 2021

Feb 14, 2022

SELL
$373.53 - $434.12 $33,617 - $39,070
-90 Reduced 4.3%
2,004 $839,000
Q3 2021

Nov 12, 2021

SELL
$396.76 - $455.92 $6,348 - $7,294
-16 Reduced 0.76%
2,094 $864,000
Q2 2021

Aug 10, 2021

SELL
$372.36 - $412.07 $40,959 - $45,327
-110 Reduced 4.95%
2,110 $835,000
Q1 2021

May 11, 2021

SELL
$357.26 - $392.57 $56,804 - $62,418
-159 Reduced 6.68%
2,220 $851,000
Q4 2020

Feb 12, 2021

BUY
$319.05 - $363.32 $713,076 - $812,020
2,235 Added 1552.08%
2,379 $864,000
Q3 2020

Nov 13, 2020

BUY
$280.08 - $347.78 $5,321 - $6,607
19 Added 15.2%
144 $48,000
Q2 2020

Aug 12, 2020

SELL
$270.93 - $320.3 $24,654 - $29,147
-91 Reduced 42.13%
125 $35,000
Q1 2020

May 12, 2020

SELL
$243.44 - $359.98 $22,639 - $33,478
-93 Reduced 30.1%
216 $60,000
Q4 2019

Feb 07, 2020

BUY
$281.18 - $322.05 $38,521 - $44,120
137 Added 79.65%
309 $99,000
Q3 2019

Nov 12, 2019

SELL
$294.25 - $341.49 $1,471 - $1,707
-5 Reduced 2.82%
172 $51,000
Q2 2019

Aug 09, 2019

SELL
$279.29 - $336.89 $13,126 - $15,833
-47 Reduced 20.98%
177 $60,000
Q1 2019

May 10, 2019

BUY
$246.18 - $297.25 $18,217 - $21,996
74 Added 49.33%
224 $66,000
Q2 2018

Jul 31, 2018

BUY
$217.98 - $237.23 $10,899 - $11,861
50 Added 50.0%
150 $35,000
Q1 2018

May 09, 2018

BUY
$218.74 - $251.43 $21,874 - $25,143
100 New
100 $23,000

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.